Advanced search×

[Acid-related diseases. How long should eradication therapy last when a proton pump inhibitor and 2 antibiotics are used: 7, 10 or 14 days?].

Montserrat Forné

Gastroenterol Hepatol 31(7):468-9 (2008) PMID 18783697

Version: za2963e q8za4 q8zb3 q8zc1 q8zd0 q8zec q8zf2 q8zg5

Similar articles you may find interesting…

  1. Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting.
    Marta M Duran, Eulàlia E Pérez, ... Dolors D Capellà

    Br J Clin Pharmacol 70(5):656-63 (2010) PMID 21039759

    Seven patients were randomized to CBM and nine to placebo. Only one patient in the CBM arm was withdrawn due to AEs. A higher proportion of patients in the CBM group experienced a complete response during the overall observation period [5/7 (71.4%) with CMB vs. 2/9 (22.2%) with placebo, the differen...
    View PDF
  2. Apoptosis resistance of mucosal lymphocytes and IL-10 deficiency in patients with steroid-refractory Crohn's disease.
    Rebeca Santaolalla, Josep Mañé, ... Maria Esteve

    Inflamm Bowel Dis 17(7):1490-500 (2011) PMID 21674705

    : Apoptosis resistance of mucosal T and B cells in steroid-refractory and -dependent CD patients appears during the evolution of the acute phase, limiting its clinical application as a predictor marker. In contrast, increased expression of IL-10 at an early stage of active steroid-sensitive CD patien...
  3. Evaluation of a latex agglutination test (PYLOGEN) for the detection of Helicobacter pylori in stool specimens
    Silvia Blanco, Montse Forné, ... Jose Domínguez

    Diagn Microbiol Infect Dis 63(4):5 (2009) PMID 19232854

    The aim of the study was to assess a new latex agglutination (LA) stool antigen assay (PYLOGEN; CerTest Biotec, Zaragoza, Spain) in the diagnosis of Helicobacter pylori infection and to monitor its eradication after treatment. The LA test has been approved for sale in Europe, and its approval from t...